BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35763763)

  • 1. Renal function and mortality in patients with atrial fibrillation.
    Liampas E; Kartas A; Samaras A; Papazoglou AS; Moysidis DV; Vrana E; Botis M; Papanastasiou A; Baroutidou A; Vouloagkas I; Karagiannidis E; Akrivos E; Tsalikakis D; Fyntanidou V; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Med (Hagerstown); 2022 Jul; 23(7):430-438. PubMed ID: 35763763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation.
    Navaravong L; Barakat M; Burgon N; Mahnkopf C; Koopmann M; Ranjan R; Kholmovski E; Marrouche N; Akoum N
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):21-7. PubMed ID: 25142836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.
    Carrero JJ; Evans M; Szummer K; Spaak J; Lindhagen L; Edfors R; Stenvinkel P; Jacobson SH; Jernberg T
    JAMA; 2014 Mar; 311(9):919-28. PubMed ID: 24595776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
    Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
    Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
    Posch F; Ay C; Stöger H; Kreutz R; Beyer-Westendorf J
    Int J Cardiol; 2019 May; 282():47-52. PubMed ID: 30777405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD.
    Bansal N; Zelnick LR; Reynolds K; Harrison TN; Lee MS; Singer DE; Sung SH; Fan D; Go AS
    J Am Soc Nephrol; 2022 Feb; 33(2):442-453. PubMed ID: 34921110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal function and outcomes after catheter ablation of patients with atrial fibrillation: The Guangzhou atrial fibrillation ablation registry.
    Deng H; Shantsila A; Xue Y; Bai Y; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019; 112(6-7):420-429. PubMed ID: 31133543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci.
    Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Ando M; Hirai M; Shibata R; Murohara T
    J Cardiol; 2017 Jan; 69(1):3-10. PubMed ID: 27499270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
    Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.
    Horio T; Iwashima Y; Kamide K; Tokudome T; Yoshihara F; Nakamura S; Kawano Y
    J Hypertens; 2010 Aug; 28(8):1738-44. PubMed ID: 20485194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.
    Carrero JJ; Trevisan M; Sood MM; Bárány P; Xu H; Evans M; Friberg L; Szummer K
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1314-1320. PubMed ID: 30030271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulants, time in therapeutic range and renal function over time in real-life patients with atrial fibrillation and chronic kidney disease.
    Batra G; Modica A; Renlund H; Larsson A; Christersson C; Held C
    Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.
    Tomaszuk-Kazberuk A; Nikas D; Lopatowska P; Młodawska E; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Sobkowicz B; Goudevenos I
    Kidney Blood Press Res; 2018; 43(6):1796-1805. PubMed ID: 30504712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.
    Airy M; Schold JD; Jolly SE; Arrigain S; Bansal N; Winkelmayer WC; Nally JV; Navaneethan SD
    Am J Nephrol; 2018; 48(1):36-45. PubMed ID: 30048961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CHA
    Beyer-Westendorf J; Kreutz R; Posch F; Ay C
    Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.
    Eikelboom JW; Connolly SJ; Gao P; Paolasso E; De Caterina R; Husted S; O'Donnell M; Yusuf S; Hart RG
    J Stroke Cerebrovasc Dis; 2012 Aug; 21(6):429-35. PubMed ID: 22818021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease.
    Kumar N; Xu H; Garg N; Pandey A; Matsouaka RA; Field ME; Turakhia MP; Piccini JP; Lewis WR; Fonarow GC
    Am Heart J; 2021 Dec; 242():45-60. PubMed ID: 34216572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there association between changes in eGFR value and the risk of permanent type of atrial fibrillation? Analysis of valvular and non-valvular atrial fibrillation population.
    Mlodawska E; Tomaszuk-Kazberuk A; Lopatowska P; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Kidney Blood Press Res; 2014; 39(6):600-8. PubMed ID: 25531163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
    Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
    Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease.
    Pastori D; Pignatelli P; Perticone F; Sciacqua A; Carnevale R; Farcomeni A; Basili S; Corazza GR; Davì G; Lip GYH; Violi F;
    Int J Cardiol; 2016 Nov; 223():619-624. PubMed ID: 27565838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.